| Product Name | MF | CAS | Details |
|---|
| Labetalol 2-hydroxy-5-((S)-1-hydroxy-2-(((S)-4-phenylbutan-2- yl)amino)ethyl) benzamide hydrochloride | C19H25ClN2O3 | 32780-64-6 | Details |
| Atomoxetine EP Impurity A N-methyl-3-phenoxy-3-phenylpropan-1-amine hydrochloride | C16H20ClNO | 873310-33-9 | Details |
| Leflunomide EP Impurity D 5-methylisoxazole-4-carboxylic acid | C5H5NO3 | 42831-50-5 | Details |
| Chlortalidone EP impurity C Chlorthalidone Acid Ethyl Ester ; 2-[3-(Aminosulfonyl)-4- chlorobenzoyl]-benzonic acid ethyl ester | C16H14ClNO5S | 92874-73-2 | Details |
| Buspirone Hydrochloride 8-[4-[4-(Pyrimidin-2-yl)piperazin-1-yl]butyl]-8-azaspiro[4.5]- decane-7,9-dione hydrochloride | C21H32ClN5O2 | 33386-08-2 | Details |
| Irbesartan Bromo N2-Trityl Impurity 5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenylmethyl-1H- tetrazole | C33H25BrN4 | 124750-51-2 | Details |
| Sitagliptin Impurity 19 (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5- trifluorophenyl)butanoic acid | C15H18F3NO4 | 486460-00-8 | Details |
| Paracetamol EP Impurity I 1-(2-hydroxyphenyl)ethan-1-one | C8H8O2 | 118-93-4 | Details |
| Aripiprazole Bromobutoxyquinoline Impurity 7-(4-Bromobutoxy)-3,4-dihydroquinolin-2-one | C13H16BrNO2 | 129722-34-5 | Details |
| Fenticonazole Nitrate 1-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)benzyl)oxy)ethyl)- 1H-imidazole nitrate | C24H21Cl2N3O4S | 73151-29-8 | Details |
| Lansoprazole EP Impurity E 2-Mercaptobenzimidazole | C7H6N2S | 583-39-1 | Details |
| Gabapentin EP Impurity B Gabapentin USP Related Compound B;(1- Cyanocyclohexyl)acetic acid | C9H13NO2 | 133481-09-1 | Details |
| Esomeprazole EP Impurity D Esomeprazole USP Related Compound A ; Esomeprazole USP RC A ; Omeprazole Sulfone | C17H19N3O4S | 88546-55-8 | Details |
| BROMO(2-FLUROPHENYL)ACETIC ACID | C8H6BrFO2 | 134770-09-5 | Details |
| Ivabradine Impurity 3 1-bromo-3-chloropropane | C3H6BrCl | 109-70-6 | Details |
| N- nitrosodiethylamine (NDEA). N-Ethyl-N-nitrosoethanamine; DEN; DENA; Diethylnitrosamide | C4H10N2O | 55-18-5 | Details |
| Desloratadine N-Methyl Impurity Loratadine EP Impurity G ;Loratadine USP RC B | C20H21ClN2 | 38092-89-6 | Details |
| Metronidazole EP impurity B 4-nitro-1H-imidazole | C3H3N3O2 | 3034-38-6 | Details |
| Ondansetron EP Impurity H 3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H- carbazol-4-one | C17H17N3O | 99614-14-9 | Details |
| Mesalazine EP Impurity B 3-aminophenol, Mesalamine EP Impurity B | C6H7NO | 591-27-5 | Details |
| 3-(3,4-Dimethoxyphenyl)-L-Alanine | C11H15NO4 | 32161-30-1 | Details |
| Picolonic acid Pyridine-2-carboxylic Acid | C6H5NO2 | 98-98-6 | Details |
| Losartan Related Compound B 4’-[(2-butyl-4-chloro-5-hydroxymethyl)-1H-imidazol-1- yl)methyl]-[1,1’-Biphenyl]-2-carbonitrile | C22H22ClN3O | 114772-55-3 | Details |
| Aripiprazole 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-3,4- dihydroquinolin-2(1H)-one | C23H27Cl2N3O2 | 129722-12-9 | Details |
| Ethacrynic Acid 2-[2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic Acid | C13H12Cl2O4 | 58-54-8 | Details |
| Lacosamide EP Impurity A (S)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide | C13H18N2O3 | 175481-37-5 | Details |
| Quetiapine EP Impurity D Quetiapine Dimer Impurity ; Quetiapine Bis(dibenzothiazepinyl) piperazine Impurity (USP) | Details |
| Apixaban acid impuity 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1- piperidinyl) phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid | C25H24N4O5 | 503614-92-4 | Details |
| Azilsartan Impurity B 1-((2'-carbamoyl-[1,1'-biphenyl]-4-yl)methyl) -2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid | C24H21N3O4 | 1696392-11-6 | Details |
| Apixaban Impurity 4 ethyl 6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7- tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | C22H22N4O4 | 503615-07-4 | Details |
| Nabumetone EP Impurity A 3-(6-methoxynaphthalen-2-yl)-5-methylcyclohexanone | C18H20O2 | 343272-52-6 | Details |
| Bupivacaine EP Impurity D (2RS)-2,6-Dichloro-N-(2,6-dimethylphenyl)hexanamide | C14H19Cl2NO | 1037184-07-8 | Details |
| Tenteligliptin impurity B tert-butyl (2S,4S)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5- yl)piperazin-1-yl)-2-(thiazolidine-3-carbonyl)pyrrolidine-1- carboxylate | C27H38N6O3S | 401566-80-1 | Details |
| Atenolol EP Impurity F 2,2'-[(1-Methylethyl)iminobis(2-hydroxypropan-3,1diyloxy-4,1- phenylene)]diacetamide | C25H35N3O6 | 87619-83-8 | Details |
| Apremilast Impurity 1 3-Ethoxy-4-methoxy-[(methylsulfonyl)methyl]-(S)- benzenemethanamine | C12H19NO4S | 608141-42-0 | Details |
| Ondansetron EP Impurity G 3-((1H-imidazol-1-yl)methyl)-9-methyl-1,2,3,9-tetrahydro-4H- carbazol-4-one | C17H17N3O | 99614-03-6 | Details |
| 4-Methyl L-Aspartate Hydrochloride 4-Methyl L-Aspartate Hydrochloride | C5H10ClNO4- | 16856-13-6 | Details |
| Amlodipine 3-ethyl 5-Methyl 2-((2-aMinoethoxy)Methyl)-4-(2-chlorophenyl) 6-Methyl-1,4-dihydropyridine-3,5-dicarboxylate Maleate | C30H35ClN2O12S | 88150-47-4 | Details |
| Paracetamol EP Impurity C N-(3-chloro-4-hydroxyphenyl)acetamide | C8H8ClNO2 | 3964-54-3 | Details |
| cis-Haloperidol N-Oxide 4-[cis-4-(4-Chlorophenyl)-4-hydroxy-1-oxido-1-piperidinyl]-1-(4- fluorophenyl)-1-butanone | C21H23ClFNO3 | 150214-94-1 | Details |
| 4-Hyrdroxy Felbamate 2-(4-Hydroxyphenyl)-1,3-propanediyl Dicarbamate | C11H14N2O5 | 109482-28-2 | Details |
| Erythromycin E-Base; E-Mycin; Erythromycin A | C37H67NO13 | 114-07-8 | Details |
| Mesalazine EP Impurity C 2-aminophenol.; Mesalamine EP Impurity C | C6H7NO | 95-55-6 | Details |
| Mycophenolate Mofetil EP Impurity F Mycophenolic Acid | C17H20O6 | 24280-93-1 | Details |
| Azilsartan Impurity D 3-((2'-(N'-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl) methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid | C22H18N4O4 | 1821386-21-3 | Details |
| Brexpiprazole N-Oxide 7-[4-(4-Benzo[b]thien-4-yl-1-oxido-1-piperazinyl)butoxy] -2(1H)-quinolinone | C25H27N3O3S | 1191900-58-9 | Details |
| Glimepiride 1-[[p-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea | C24H34N4O5S | 93479-97-1 | Details |
| Lidocaine EP Impurity A Bupivacaine EP Impurity F ; Lidocaine USP Impurity A ; 2,6- Dimethylaniline | C8H11N | 87-62-7 | Details |
| Phenylephrine EP Impurity E Phenylephrine Related Compound E ; 2-(benzylmethylamino)-1-(3-hydroxyphenyl)ethanone ; benzylphenylephrone | C16H17NO2 | 56917-44-3 | Details |
| Bumetanide EP Impurity B Bumetanide Related Compound A ; 3-amino-4-phenoxy-5- sulfamoylbenzoic acid ; Desbutyl Bumetanide | C13H12N2O5S | 28328-54-3 | Details |
| Ethyl 3-(2-Pyridylamino)propionate | C10H14N2O2 | 103041-38-9 | Details |
| Meloxicam EP Impurity E methyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide | C11H11NO5S | 35511-15-0 | Details |
| 1-Benzhydrylpiperazine | C17H20N2 | 841-77-0 | Details |
| Pantoprazole 5-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2- yl)methyl)sulfinyl)-1H-benzo[d]imidazole | C16H15F2N3O4S | 102625-70-7 | Details |
| Glipizide EP Impurity B cyclohexanamine | C6H13N | 108-91-8 | Details |
| Piroxicam EP Impurity A pyridin-2-amine | C5H6N2 | 504-29-0 | Details |
| Paracetamol EP Impurity G (E)-1-(4-hydroxyphenyl)ethanone oxime | C8H9NO2 | 198712-64-0 | Details |
| Mycophenolate Mofetil EP Impurity E Mycophenolic Acid Methyl Ester | C18H22O6 | 31858-66-9 | Details |
| Celecoxib Impurity 3 4-(5-phenyl-3-(trifluoromethyl)-1H-pyrazol-1- yl)benzenesulfonamide | C16H12F3N3O2S | 170569-87-6 | Details |
| Piroxicam EP Impurity L 1-methylethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3- carboxylate 1,1-dioxide | C13H15NO5S | 118854-48-1 | Details |
| Chlortalidone EP impurity B Chlorthalidone USP RC A ; Chlorthalidone Acid ; 2-[3-(Aminosulfonyl)-4-chlorobenzoyl]-benzonic acid | C14H10ClNO5S | 5270-74-6 | Details |
| Mesalazine EP Impurity I 2-hydroxy-5-(phenyldiazenyl)benzoic acid (phenylazosalicylic acid).; Mesalamine EP Impurity I | C13H10N2O3 | 3147-53-3 | Details |
| (3Z)-4-Hydroxy-4-(6-methoxy-2-naphthalenyl)-3-buten- 2-one | C15H14O3 | 218768-11-7 | Details |
| Amlodipine EP impurity A Amlodipine USP RC D,Phthaloyl Amlodipine | C28H27ClN2O7 | 88150-62-3 | Details |
| Montelukast EP Impurity C Montelukast USP Related Compound A ; Montelukast Sulfoxide | C35H36ClNO4S | 909849-96-3 | Details |
| Rabeprazole EP Impurity A Rabeprazole USP Related Compound D ; Rabeprazole Sulfone ; | C18H21N3O4S | 117976-47-3 | Details |
| Rivaroxaban 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5- oxazolidinyl] methyl]-2-thiophenecarboxamide | C19H18ClN3O5S | 366789-02-8 | Details |
| Lidocaine Anestacon ; 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide | C14H22N2O | 137-58-6 | Details |
| Desloratadine N-Acetyl Impurity Desloratadine N-Acetyl Impurity ; N-Acetyl Desloratadine | C21H21ClN2O | 117796-52-8 | Details |
| Paracetamol EP Impurity H 4-acetamidophenyl acetate | C10H11NO3 | 2623-33-8 | Details |
| Ethacrynic Acid impurity A 4-Butanoyl-2, 3-dichlorophenoxy acetic acid | C12H12Cl2O4 | 1217-67-0 | Details |
| Teriflunomide Impurity 18 2-cyano-N-(4-(trifluoromethyl)phenyl)acetamide | C10H7F3N2O | 24522-30-3 | Details |
| Tirofiban (S)-2-(butylsulfonamido)-3-(4-(4-(piperidin-4- yl)butoxy)phenyl)propanoic acid | C22H36N2O5S | 144494-65-5 | Details |
| Hydrochlorothiazide EP Impurity B Hydrochlorothiazide USP Related Compound A | C6H8ClN3O4S2 | 121-30-2 | Details |
| Mesalazine EP Impurity R 2-hydroxy-3-nitrobenzoic acid (3-nitrosalicylic acid). ; Mesalamine EP Impurity R | C7H5NO5 | 85-38-1 | Details |
| Mesalazine EP Impurity F 3-amino-2-hydroxybenzoic acid (3-aminosalicylic acid).; Mesalamine EP Impurity F | C7H7NO3 | 570-23-0 | Details |
| Thiamazole | C4H6N2S | 60-56-0 | Details |
| Memantine HCl 3,5-Dimethyltricyclo[3.3.1.13,7]decan-1-amine hydrochloride | C12H22ClN | 41100-52-1 | Details |
| Oxcarbazepine 10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide | C15H12N2O2 | 28721-07-5 | Details |
| Lacosamide EP Impurity D (2R)-2-Amino-3-methoxy-N-(phenylmethyl)-propanamide. BP Impurity D | C11H16N2O2 | 196601-69-1 | Details |
| Amlodipine EP Impurity E Amlodipine Diethyl Ester; 2-[(2-Aminoethoxy)methyl]-4-(2- chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic Acid 3,5-Diethyl Ester | C21H27ClN2O5 | 140171-65-9 | Details |
| Lacosamide EP Impurity F Desmethyl Lacosamide(Hydroxy Imp) | C12H16N2O3 | 175481-38-6 | Details |
| Quetiapine EP Impurity I HCl Salt Quetiapine Desethoxy Impurity (USP) ; Quetiapine Alcohol Impurity | C19H21N3OS | 329218-14-6 | Details |
| Atenolol EP Impurity E 2,2'-[2-Hydroxypropan-1,3-diylbis(oxy-4,1- phenylene)diacetamide | C19H22N2O5 | 141650-31-9 | Details |
| Desloratadine N-Hydroxy Impurity | C19H19ClN2O | 1193725-73-3 | Details |
| Azilsartan medoxomil potassium | C30H25KN4O8 | 863031-24-7 | Details |
| Olanzapine Amino Impurity 2-(2-Aminoanilino)-5-methylthiophene-3-carbonitrile | C12H11N3S | 873895-41-1 | Details |
| Haloperidol EP Impurity B Haloperidol Related Compound B | C21H23ClFNO2 | 1391052-53-1 | Details |
| Donepezil hydroxy impurity 2,3-Dihydro-2-[hydroxy[1-(phenylmethyl)-4-piperidinyl]methyl]- 5,6-dimethoxy-1H-inden-1-one | C24H29NO4 | 197010-20-1 | Details |
| Leflunomide EP Impurity G 5-methyl-N-(p-tolyl)isoxazole-4-carboxamide | C12H12N2O2 | 724429-16-7 | Details |
| Tenegliptin impurity A 1-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine | C14H18N4 | 401566-79-8 | Details |
| Azilsartan Impurity A methyl 1-((2'-carbamoyl-[1,1'-biphenyl]-4-yl)methyl) -2-ethoxy-1H-benzo[d]imidazole-7-carboxylate | C25H23N3O4 | 147404-76-0 | Details |
| Montelukast (3RS)-Hydroxy Propanol | C29H28ClNO2 | 959235-68-8 | Details |
| Descyano Diclazuril Ketone (Impurity D) 2-[3,5-Dichloro-4-(4-chlorobenzoyl)phenyl]-1,2,4-triazine- 3,5(2H,4H)-dione | C16H8Cl3N3O3 | 133648-81-4 | Details |
| Quetiapine Fumarate 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1- piperazinyl)ethoxy]ethanol hemifumarate | C25H29N3O6S | 111974-72-2 | Details |
| Dabigatran Impurity 9 Dabigatran Etexilate Methyl Ester Analog | C33H39N7O5 | 211915-00-3 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 | ||||